These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23488511)

  • 1. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.
    Schwartz RP; Gryczynski J; O'Grady KE; Sharfstein JM; Warren G; Olsen Y; Mitchell SG; Jaffe JH
    Am J Public Health; 2013 May; 103(5):917-22. PubMed ID: 23488511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efforts to reduce overdose deaths.
    Sherman SG; Han J; Welsh C; Chaulk P; Serio-Chapman C
    Am J Public Health; 2013 Aug; 103(8):e1-2. PubMed ID: 23763429
    [No Abstract]   [Full Text] [Related]  

  • 3. Schwartz et al. respond.
    Schwartz RP; Gryczynski J; O'Grady KE; Sharfstein JM; Warren G; Olsen YK; Mitchell SG; Jaffe JH
    Am J Public Health; 2013 Aug; 103(8):e2-3. PubMed ID: 23763406
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deaths attributable to methadone vs buprenorphine in France.
    Auriacombe M; Franques P; Tignol J
    JAMA; 2001 Jan; 285(1):45. PubMed ID: 11150107
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
    Sordo L; Barrio G; Bravo MJ; Indave BI; Degenhardt L; Wiessing L; Ferri M; Pastor-Barriuso R
    BMJ; 2017 Apr; 357():j1550. PubMed ID: 28446428
    [No Abstract]   [Full Text] [Related]  

  • 7. Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.
    Schwartz RP; Kelly SM; Gryczynski J; Mitchell SG; O'Grady KE; Jaffe JH
    J Addict Dis; 2015; 34(2-3):151-61. PubMed ID: 26079104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
    Lepère B; Gourarier L; Sanchez M; Adda C; Peyret E; Nordmann F; Ben Soussen P; Gisselbrecht M; Lowenstein W
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.
    Marotta PL; McCullagh CA
    Eur J Epidemiol; 2018 Jul; 33(7):679-688. PubMed ID: 29234968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.
    Toce MS; Chai PR; Burns MM; Boyer EW
    J Med Toxicol; 2018 Dec; 14(4):306-322. PubMed ID: 30377951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin.
    Hickman M; Madden P; Henry J; Baker A; Wallace C; Wakefield J; Stimson G; Elliott P
    Addiction; 2003 Apr; 98(4):419-25. PubMed ID: 12653812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy.
    Pajusco B; Chiamulera C; Quaglio G; Moro L; Casari R; Amen G; Faccini M; Lugoboni F
    Int J Environ Res Public Health; 2012 Mar; 9(3):932-42. PubMed ID: 22690174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis.
    Bahji A; Cheng B; Gray S; Stuart H
    Acta Psychiatr Scand; 2019 Oct; 140(4):313-339. PubMed ID: 31419306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
    Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
    Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine in the treatment of opioid dependence.
    George S; Day E
    Br J Hosp Med (Lond); 2007 Nov; 68(11):594-7. PubMed ID: 18087846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance drugs to treat opioid dependence.
    Farrell M; Wodak A; Gowing L
    BMJ; 2012 May; 344():e2823. PubMed ID: 22589497
    [No Abstract]   [Full Text] [Related]  

  • 18. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescents at risk: pain pills to heroin: part II.
    Fogger S; McGuinness TM
    J Psychosoc Nurs Ment Health Serv; 2015 Feb; 53(2):27-30. PubMed ID: 25654572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.